Copper-64 (T1/2= 12.7 h) is a positron and beta-emitting isotope, with decay characteristics
suitable for both positron emission tomography (PET) imaging and radiotherapy of cancer …

Most patients with advanced prostate cancer (PCa) will develop metastatic castration-
resistant prostate cancer (mCRPC) after androgen deprivation therapy, at this time the tumor …

The utility of sterically hindered phenols (SHPs) in drug design is based on their
chameleonic ability to switch from an antioxidant that can protect healthy tissues to highly …

Prostate cancer is the second most common type of cancer among men. Its main method of
treatment is chemotherapy, which has a wide range of side effects. One of the solutions to …

Prostate cancer is one of the most commonly diagnosed men's cancers and remains one of
the leading causes of cancer death. The development of approaches to the treatment of this …

177Lu-labeled small-molecule prostate-specific membrane antigen (PSMA) targeted tracers
are therapeutic agents for metastatic castration-resistant prostate cancer. Optimizing …

Tumour-targeted near-infrared (NIR) optical imaging is an emerging tool for the detection of
malignant tissues. This modality can be useful in both diagnosis and intraoperative …

Prostate-specific membrane antigen (PSMA) has been identified as a target for the
development of theranostic agents. In our current work, we describe the design and …

Prostate cancer is the second most common type of cancer among men. The main method of
its treatment is androgen deprivation therapy, which has a wide range of side effects. One of …

Prostate-specific membrane antigen (PSMA) imaging probes are a promising tool for the
diagnosis and image-guided surgery of prostate cancer (PCa). However, PSMA-specific …